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IL-8 Immunoreactivity Is Diminished in Inflammatory Psoriasis 
As growing numbe~s of proteins involved in cell~to-cell communi-
cation are charac~enzed, the pr?I'osed genes1s ofb10log1c eve?'ts that 
require cooperatH_m of n:any different types of cells, such as mflam-
mation, becomes mcreasmgly complex. One of these recently Iden-
tified proteins is known as IL-8, or neutrophil-activating peptide. 
This cytokine has been previously detected in psoriatic scale, thus 
leading to questio~s about _whether ~t may _represent an important 
signal from the ep1den!us mvolved 111 the mflammatory events of 
psoriasis, or whether 1t IS a product of other cells known to produce 
IL-8, such as leukocytes. 
In this issue of the JID, Sticherling and colleagues from the Uni-
versity ofKeil in Germany describe the results of studies of normal 
and psoriatic skin for the presence of immunoreactive IL-8. As tools 
for detection ofiL-8, they used two monoclonal antibodies to IL-8. 
When sections of normal skin were stained for IL-8 in an indirect 
immunoperoxidase procedure, intracellular staining of keratino-
cytes above the basal cell layer was seen with one antibody, whereas 
staining of the entire cellular portion of the epidermis, particularly 
the basal cell layer, was seen with the other. In lesional psoriatic skin 
with marked inflammation and with parakeratosis, positive staining 
with the first antibody was diminished, whereas in psoriatic skin 
with minimal inflammation and in uninvolved skin from psoriatics, 
the staining was similar to that of normal skin. In the areas of 
diminished staining, the cells of sweat ducts and hair follicles con-
tinued to stain in a normal manner. 
In other studies by these investigators, immunoreactive IL-8-
like material from normal epidermis has not been shown to have 
IL-8 biologic activity. They propose that this material may be IL-8-
like molecules, perhaps precursors of the active form. We do not yet 
know if the IL-8 immunoreactivity that appears to be diminished in 
active psoriasis represents depletion of an immunoreactive but bio-
logically inactive pool, similar to that thought to occur in normal 
skin, or if this pool is, or is converted to, a biologically active form. If 
the immunoreactive IL-8 -like material in psoriatic epidermis is not 
active, then the IL-8 activity of psoriatic scale is likely derived from 
inflammatory cells. However, if it is active, then IL-8 may be an 
epidermal cytokine important in the pathogenesis of psoriasis. 
T -Lymphocytes Cultured from Involved and Uninvolved Skin of Psoriasis Patients May Be Autoreactive 
In examination of the hypothesis that psoriasis may fundamentally 
be an immunologic disease, researchers have recently focused on the 
role oflymphocytes, even though such cells are not usually the most 
abundant inflammatory cell in psoriatic skin. In this issue Dr. Afzal 
Nikaein and co-workers at Baylor University Medical Center in 
Dallas report results of their attempts to characterize the lympho-
cytes present in the skin of psoriasis patients, both by immunopath-
ologic examination of skin biopsies and by study of lymphocytes 
cultured from biopsies. By immunopathology the lymphocytes 
present in involved and uninvolved skin of psoriatics included a 
mixture of helper and suppressor T lymphocytes, without B lym-
phocytes. Culture results were interesting in that T lymphocytes 
could be cultured from both involved and uninvolved skin of psoria-
sis patients but not from the skin of normal control subjects. A 
mixture ofT -lymphocyte types, similar to those seen by histopath-
ology, were identified by flow cytometry of the cultured cells. The 
cultured cells did not produce lysis of autologous or allogeneic tar-
get cells or natural killer cytolytic activity. However, in the primed 
lymphocyte test, the cultured lymphocytes from psoriatic skin pro-
liferated when incubated with autologous cells, as well as with some 
allogeneic cells with known HLA types . Proliferation did not ap-
pear to be determined by major HLA antigens. Dr. Nikaein believes 
that these results point to the lymphocytes in psoriatic skin being 
autoreactive, recognizing minor histocompatibility antigens. If this 
evidence can be verified by additional studies, and lymphocytes 
cultured from other skin diseases examined as controls, perhaps this 
will be an important step forward in understanding how the im-
mune system plays a role in the pathogenesis of psoriasis. 
Transforming Growth Factor-B1 May Be A Signal-Mediating Fibrosis in the 
Eosinophilia-Myalgia Syndrome 
The Eosinophilia-Myalgia Syndrome (EMS), related to the con-
sumption of L-tryptophan, has provided an unusual opportunity for 
study of mechanisms of fibrosis that may be pertinent to other 
fibrotic diseases, such as scleroderma. In this issue of the JID Dr. 
Sergio Jimenez and colleagues at Thomas Jefferson University re-
port the results of examination of the fascia of EMS for the expres-
sion of three proteins that may be important in fibrosis: fibronectin, 
type VI collagen, and transforming growth factor-B 1 (TGF-B 1 ). 
In the thickened fascia of patients with EMS the expression of all 
three proteins, evaluated by immunofluorescence and immunoper-
oxidase techniques, was thought to be increased. Furthermore, in-
creased messenger RNA for type VI collagen and for TGF-B1 were 
detected in the thickened fascia by in situ hybridization. These 
results are most significant in that they indicate that the fibroblastic 
cells in the involved fascia of EMS produce the cytokine, TGF-B 1 • 
Similar findings have previously been reported in other fibrotic 
diseases of the skin. According to Dr. Jimenez, this study of EMS 
fascia provides further evidence that TGF-B 1 may be a crucial signal 
111 the pathogenesis of fibros1s . Even though the initiating factors in 
the different fibrotic diseases may be different, the genes that are 
activated and _lead to fibrosis may be the same. TGF-B1 appears to be 
one of these Important genes along the path to fibrosis. 
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Lipid Abnormalities May Characterize Atopic Dermatitis Epidermis, But Generalized Abnormalities in 
Fatty Acids Do Not Occur . 
Despite decades of research into the causes of atopic dermatitis, the 
basic defects remain mysteries. Although much evidence points to a 
role of the immune system at some step in the pathogenesis, investi-
gators cannot escape the rather obvious fact that there appears to be 
something different about atopic skin. Tendencies to dryness and to 
itch are essential characteristics of such skin. Investigators interested 
in atopic dermatitis have therefore theorized that defects in epider-
mal lipids might explain the innate abnormality of such skin. Be-
cause lipids are the major determinants of the epidermal barrier 
function and because certain lipids may funnel into the pathway of 
inflammatory mediators known as eicosanoids, this has been a popu-
lar theory. 
In this issue Dr. Liselotte Schafer and co-workers from Stock-
holm report in two papers the results of examination of two hypoth-
eses regarding lipid-related abnormalities that may be present in 
subjects with atopic dermatitis. The first is that abnormalities in 
phospholipids occur in atopic epidermis; the second is that a defect 
in desaturation of fatty acids characterizes this disease. 
For study of epidermal lipids, epidermal samples were taken with 
a keratome from involved and uninvolved skin of selected atopic 
dermatitis patients and from normal skin of women undergoing 
breast surgery. Both involved and uninvolved atopic skin had 
higher levels of the phosphoglycerides phosphatidylethanolamine 
and phosphatidylcholine than the normal skin, whereas the content 
of arachidonic acid in these phosphoglycerides was lower than that 
of non-atopic skin. Differences between the involved and unin-
volved atopic epidermis in the fatty acid profiles included increased 
monosaturated fatty acids in the phosphoglycerides, decreased n-6 
fatty acids, higher free arachidonic acid, and decreased long-chain 
saturated fatty acids in the lesional epidermis. 
The abnormalities noted in this study could be significant in 
understanding atopic skin. Dr. Schafer believes that the differences 
between atopic epidermis and non-atopic epidermis are real and do 
not represent regional differences in epidermal lipids. If, as proposed 
by Dr. Schafer, phospholipase A2 activity is increased in atopic epi-
dermis, and conversion of the fatty acids released by this enzyme 
into other lipid products, such as lipid determinants of the stratum 
corneum barrier function, is defective, then we might finally under-
stand what is different about atopic skin. 
In the second study, the fatty acid profiles of phospholipids of 
neutrophils and of triglycerides from adipose tissue were measured 
in atopic subjects and matched control subjects. The fatty-acid pro-
files were similar for the two groups. Despite similar arachidonic 
acid content of the neutrophils, stimulated neutrophils of atopic 
subjects released significantly less leukotriene B4 • The results of this 
study dispute the theory that abnormal fatty-acid desaturation oc-
curs in atopic dermatitis and raise some questions about the rationale 
for dietary therapy with unsaturated fatty acids. It also shows that 
some abnormalities in the eicosanoid pathway may be found in the 
neutrophils of atopic dermatitis patients. Understanding whether 
this is a consistent abnormality, whether it is present in other cells, 
and whether it is pertinent to the pathogenesis of atopic dermatitis , 
will require more detailed studies. 
